Christmas Patrick J. 4
4 · REGENXBIO Inc. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Christmas Patrick J.
Chief Strategy & Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-12$12.10/sh+4,701$56,882→ 21,073 total - Sale
Common Stock
2021-02-12$49.08/sh−4,701$230,725→ 16,372 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-02-12−4,701→ 6,430 totalExercise: $12.10Exp: 2026-08-17→ Common Stock (4,701 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $49.00 to $49.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]The previously granted option, representing a right to purchase a total of 125,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 18, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.